![Valerie Start](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Valerie Start
Directeur/Membre du Conseil chez
ERASCA, INC.
Fortune : 393 360 $ au 31/08/2026
Profil
Valerie Denise Harding Start is currently an Independent Director at Erasca, Inc. since 2019, a Member & Partner at Smallify LLC, and Principal at Start Pharma Consulting LLC since 2019.
Formerly, Dr. Start was Vice President-Product Differentiation at Pfizer Inc. in 2012 and Senior VP-Chemistry, Manufacturing & Controls at Ignyta, Inc. from 2015 to 2019.
Dr. Start completed undergraduate studies at the University of London and earned a doctorate from The University of Nottingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ERASCA, INC. 0,01% | 26/06/2026 | 22 000 ( 0,01% ) | 393 360 $ | 31/08/2026 |
Postes actifs de Valerie Start
| Sociétés | Poste | Début |
|---|---|---|
| ERASCA, INC. | Directeur/Membre du Conseil | 01/06/2019 |
Start Pharma Consulting LLC | Corporate Officer/Principal | 01/02/2019 |
Smallify LLC
 Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Corporate Officer/Principal | - |
Anciens postes connus de Valerie Start
| Sociétés | Poste | Fin |
|---|---|---|
| IGNYTA INC | Corporate Officer/Principal | 01/01/2019 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Valerie Start
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Commercial Services |
Start Pharma Consulting LLC |
